CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock [Member]	Additional Paid-In Capital	Stock Payable	Accumulated Deficit	Noncontrolling Interest	Total
Beginning Balance, Shares at Dec. 31, 2016	23,336,673
Beginning Balance, Amount at Dec. 31, 2016	$ 23,337	$ 12,412,430		$ (10,718,714)		$ 1,717,053
Issuance of common stock for professional services, Shares	564,579
Issuance of common stock for professional services, Amount	$ 565	2,204,435				2,205,000
Warrants granted		1,181,057				1,181,057
Common stock owed but not yet issued		(828)	324,995			324,167
Loan discounts		686,538				686,538
Noncontrolling interest of Oak Therapeutics, Inc.					46,884	46,884
Net loss				(8,149,885)		(8,149,885)
Ending Balance, Shares at Dec. 31, 2017	23,901,252
Ending Balance, Amount at Dec. 31, 2017	$ 23,902	16,483,632	324,995	(18,868,599)	46,884	(1,989,186)
Issuance of common stock for professional services, Shares	1,871,657
Issuance of common stock for professional services, Amount	$ 1,872	2,275,993	14,583			2,292,448
Warrants granted		662,632				662,632
Issuance of common stock for cancellation of accounts payable, Shares	94,444
Issuance of common stock for cancellation of accounts payable, Amount	$ 94	99,044				99,138
Issuance of common stock for purchase of patents, Shares	170,000
Issuance of common stock for purchase of patents, Amount	$ 170	237,330	42,600			280,100
Issuance of common stock for extension of maturity dates relating to convertible promissory notes, Shares	330,000
Issuance of common stock for extension of maturity dates relating to convertible promissory notes, Amount	$ 330	646,170				646,500
Issuance of common stock for cash, Shares	416,666
Issuance of common stock for cash, Amount	$ 417	499,583				500,000
Beneficial conversion features		1,677,072				1,677,072
Fair value of stock options and restricted stock granted		843,281				843,281
Common stock payable for note conversion			263,397			263,397
Noncontrolling interest of Oak Therapeutics, Inc.					(30,472)	(30,472)
Net loss				(10,400,401)		(10,400,401)
Ending Balance, Shares at Dec. 31, 2018	26,784,019
Ending Balance, Amount at Dec. 31, 2018	$ 26,785	$ 23,424,737	$ 645,575	$ (29,269,000)	$ 16,412	$ (5,155,491)